Your supplement
stack
14 compounds · 4 Foundation · 7 Targeted · 3 Optimise
Hello Alex, here is your report.
A Note on Your Recommendations
Your profile generated 14 personalised recommendations, built around four goals you ranked in order: sustained energy and mental clarity, sleep quality, stress resilience, and longevity as a background priority. The compounds in this report are sequenced to address those goals without adding to the two frustrations you described most clearly - the mid-afternoon crash and the sleep that will not come easily.
Your Creatine Monohydrate, which you have been taking for six months, is retained as-is. It is not counted in the 14 new compounds. Everything below is additive to what you are already doing.
Foundation compounds are the four highest-scoring entries across your full profile. They address the most likely nutritional gaps given your lifestyle: a sedentary, office-based week with limited sun exposure, a diet that is reasonably balanced but inconsistent, and a fatigue pattern that may partly reflect micronutrient insufficiency. They go in first, introduced one per week, because establishing them creates the substrate everything else builds on. Without adequate Vitamin D, Magnesium, Omega-3, and Zinc, the goal-specific compounds that follow are working against a headwind.
Targeted compounds are the seven compounds chosen specifically for your stated goals. They address the energy and clarity you lose by mid-afternoon, the sleep onset and maintenance problems you have had for some time, and the stress resilience you want to rebuild. Some of these compounds take weeks to reach full effect - that is expected, and each card tells you when to start noticing a change.
Optimise compounds are three additions for the longevity and performance dimensions of your profile. Two of them carry Grade B evidence and one is a useful addition to the cognitive stack. They come in last, after the Foundation and Targeted layers are established, because building in sequence means you can actually tell what is working.
On evidence grades: Grade A means the compound has been tested in multiple randomised controlled trials, often replicated across different research groups and populations - the highest standard available. Grade B means at least one well-designed RCT supports the use, with consistent results, but with less replication than Grade A. Grade C means early-stage human data: the mechanism is plausible, initial studies are promising, but the evidence is not yet at the same level of certainty. Every Grade C compound in this report is labelled clearly. No Grade D compounds are included.
One practical note on cost: if budget is a consideration, the four Foundation compounds represent a complete and meaningful starting point on their own. The Targeted and Optimise layers are additions, not requirements. Significant benefit is available from Foundation alone, and you can build from there.
If anything in this report raises questions, reply to your report email and we will respond directly.
Your Creatine Monohydrate, which you have been taking for six months, is retained as-is. It is not counted in the 14 new compounds. Everything below is additive to what you are already doing.
Foundation compounds are the four highest-scoring entries across your full profile. They address the most likely nutritional gaps given your lifestyle: a sedentary, office-based week with limited sun exposure, a diet that is reasonably balanced but inconsistent, and a fatigue pattern that may partly reflect micronutrient insufficiency. They go in first, introduced one per week, because establishing them creates the substrate everything else builds on. Without adequate Vitamin D, Magnesium, Omega-3, and Zinc, the goal-specific compounds that follow are working against a headwind.
Targeted compounds are the seven compounds chosen specifically for your stated goals. They address the energy and clarity you lose by mid-afternoon, the sleep onset and maintenance problems you have had for some time, and the stress resilience you want to rebuild. Some of these compounds take weeks to reach full effect - that is expected, and each card tells you when to start noticing a change.
Optimise compounds are three additions for the longevity and performance dimensions of your profile. Two of them carry Grade B evidence and one is a useful addition to the cognitive stack. They come in last, after the Foundation and Targeted layers are established, because building in sequence means you can actually tell what is working.
On evidence grades: Grade A means the compound has been tested in multiple randomised controlled trials, often replicated across different research groups and populations - the highest standard available. Grade B means at least one well-designed RCT supports the use, with consistent results, but with less replication than Grade A. Grade C means early-stage human data: the mechanism is plausible, initial studies are promising, but the evidence is not yet at the same level of certainty. Every Grade C compound in this report is labelled clearly. No Grade D compounds are included.
One practical note on cost: if budget is a consideration, the four Foundation compounds represent a complete and meaningful starting point on their own. The Targeted and Optimise layers are additions, not requirements. Significant benefit is available from Foundation alone, and you can build from there.
If anything in this report raises questions, reply to your report email and we will respond directly.
Dietary Baseline
Dietary Baseline
Diet pattern
Omnivore. Breakfast skipped most days or replaced with black coffee. Lunch from a café (sandwich or salad). Home-cooked dinner most evenings, centred on chicken, pasta, and occasional red meat. Self-rated 6 out of 10: reasonably balanced but inconsistent. Around 2 cups of coffee daily, both before noon. Alcohol 3–4 units per week, mostly at weekends.
Overall baseline classification
Moderate baseline. The diet provides a reasonable foundation but has identifiable gaps: low fermented food intake, inconsistent micronutrient coverage, minimal breakfast, and a pattern of skipping meals that likely contributes to the mid-afternoon energy drop. The compound stack is designed to bridge the gaps most likely to be affecting your energy, sleep, and cognition.
Vitamin D
Limited sun exposure Monday to Friday as an office-based worker. UK latitude year-round means dietary synthesis is insufficient from approximately October through April regardless of skin type, and summer synthesis is limited for anyone spending the majority of daylight hours indoors. Dietary Vitamin D from chicken, eggs (4–5 per week), and occasional oily fish provides some contribution but falls well short of therapeutic levels. Supplementation is clearly indicated year-round. No blood test available to confirm baseline - testing is flagged in the Important Notices section.
Omega-3 EPA/DHA
Oily fish once per week provides a partial dietary contribution, approximately 0.5–0.7g combined EPA+DHA per serving. This is below the 2g+ combined EPA+DHA that is clinically relevant for cardiovascular family history, stress resilience, and cognitive support. Supplementation at standard therapeutic dose is indicated. If oily fish consumption increases to two or more times per week consistently, the supplement dose could be reviewed at the 12-week reassessment.
Magnesium
Nuts and seeds 2–3 times per week, some wholegrains, and leafy greens 2–3 times per week contribute a moderate dietary magnesium intake - likely in the range of 180–250mg per day. This falls short of optimal levels (320–420mg for adult males), particularly under stress and during regular resistance training, both of which increase magnesium demand. Magnesium Glycinate supplementation at therapeutic dose is indicated.
Zinc
White meat 3–4 times per week, eggs regularly, and red meat once per week provide a reasonable dietary zinc base. Zinc from animal sources is well-absorbed. Supplemental zinc is still included in the stack, primarily because cognitive performance and testosterone maintenance benefit from dosing at the upper range of adequacy - the goal is not deficiency correction but functional optimisation. A lower therapeutic dose (15mg elemental, rather than 25mg) is appropriate given your dietary intake.
Folate / B vitamins
Leafy greens 2–3 times per week and legumes once or twice per week provide some dietary folate. This is a partial contribution. B vitamin status more broadly is likely suboptimal given breakfast-skipping, inconsistent meals, and moderate stress - all of which increase B vitamin demand. MTHFR status is unknown; the stack uses 5-MTHF (methylfolate) as the default folate form to bypass the conversion step. A B Complex with active forms is indicated.
Vitamin B12
Omnivorous diet with regular chicken, eggs, and dairy provides adequate dietary B12 for a 34-year-old male with no absorption concerns. B12 supplementation is covered within the B Complex and does not require standalone supplementation at this stage.
Iron / Ferritin
Dietary iron from red meat (once per week), white meat (3–4 times per week), and eggs is a reasonable intake for a non-menstruating adult male. However, the persistent fatigue and mid-afternoon energy crash described in your goals context mean low ferritin cannot be excluded without testing - ferritin below 50 µg/L is associated with cognitive symptoms and fatigue even when haemoglobin is within the normal laboratory range. A ferritin blood test is recommended before assuming iron adequacy. Iron supplementation is not included in the stack without confirmed deficiency.
Calcium
Daily dairy (milk in coffee, occasional yoghurt) provides a reasonable dietary calcium contribution, likely 400–600mg per day. No bone health goal is ranked and no osteoporosis family history is present. Calcium supplementation is not indicated. The D3+K2 and Magnesium foundation addresses bone maintenance adequately at this age.
Selenium
No Brazil nuts reported, but chicken (a moderate selenium source) appears 3–4 times per week. Selenium intake is likely at the lower end of adequate for a UK omnivore. Selenium is not a priority for this stack given the absence of thyroid or fertility goals, but if a longevity stack is extended at reassessment, selenomethionine would be relevant to revisit.
Choline
4–5 eggs per week provides a meaningful choline contribution (approximately 125mg per egg). Adequate for general cognitive function at this age and intake level. No additional supplementation required at this stage.
Vitamin C
1–2 fruit portions daily and 2–3 vegetable portions provide partial dietary Vitamin C, likely 60–100mg per day - close to the RDA but below levels relevant for antioxidant and stress-demand purposes. Occasional Vitamin C gummies (current supplement) are not providing consistent coverage. See Current Supplements section below for the recommended approach.
Gut microbiome / fermented foods
Fermented food intake is rare. No probiotic supplement is in the current stack, and gut health is not a ranked goal. This is noted as a background gap: if energy, cognitive performance, or stress resilience do not respond as expected at 12 weeks, expanding dietary fermented food intake (live yoghurt, kefir, kimchi) or adding a probiotic is worth considering at reassessment. For now, the occasional yoghurt provides minimal probiotic exposure.
Fibre and gut substrate
Mixed wholegrains and refined carbs, legumes once or twice per week, and 2–3 vegetable portions daily suggest moderate fibre intake - probably 18–22g per day, below the 30g target. No specific gut health goal is ranked, and Psyllium Husk is not in the stack. Increasing legume and vegetable frequency would be the most impactful dietary change for fibre without supplementation.
UPF intake
2–3 times per week (crisps, occasional ready meal) is moderate and consistent with a generally reasonable diet. This level is not a clinical concern but contributes to micronutrient dilution - one of the reasons the B Complex and Magnesium are prioritised in the Foundation tier.
Meal timing and the afternoon slump
Skipping breakfast and relying on black coffee before noon is a likely contributor to the 2–3pm energy drop you described. This creates a glycaemic and nutrient gap in the morning that lunch partially compensates for, followed by an inevitable energy trough in the early afternoon. The compound stack addresses the biochemical side of this - particularly B vitamins, Ashwagandha, and Rhodiola - but a consistent breakfast or mid-morning snack containing protein would amplify the effect. This is not a requirement, but it is the single most impactful dietary change available for the afternoon slump outside of supplementation.
Caffeine and sleep interaction
Two cups of coffee, both before noon, is a reasonable pattern - the caffeine half-life of approximately 5–6 hours means it is largely cleared by early evening. This is unlikely to be the primary driver of your sleep onset problem, though it may be contributing marginally if either cup is consumed after 10am. The additional coffee you reach for during the afternoon slump is more likely to be interfering with sleep onset. The goal-stack approach here is to address the root cause of the slump so the afternoon coffee becomes unnecessary. Noted in the Sleep Stack section.
Food-first notes
Oily fish once per week is a meaningful Omega-3 source but insufficient for the therapeutic goals in this stack. Leafy greens 2–3 times per week provides partial folate but not enough to make B Complex redundant. Dairy daily provides calcium adequacy and reduces the case for calcium supplementation. Eggs 4–5 times per week contribute meaningfully to choline, B12, and zinc. The diet is working - it just has consistent gaps in the areas that matter most for your goals.
Important Notices
No medication interactions
You are not taking any prescription medications. No drug-supplement interactions apply to this stack. All 14 compounds are appropriate for your profile without GP pre-approval, subject to the blood work recommendations below.
Blood work recommended before or shortly after starting
Vitamin D (25-OH): No recent blood test available. Limited sun exposure and an indoor working week make deficiency likely. Testing before starting - or at the 12-week mark - will confirm whether the selected dose is achieving repletion. Target range: 100–150 nmol/L.
Ferritin: Persistent fatigue and the mid-afternoon slump you described can reflect low ferritin even when haemoglobin is within the normal laboratory range. Ferritin below 50 µg/L is associated with cognitive symptoms and reduced energy. Your dietary iron intake is adequate for a male omnivore, but testing is the only way to rule this out as a contributing factor. If ferritin is low, iron supplementation would be considered at reassessment.
Lipid panel (total cholesterol, LDL, HDL, triglycerides): First-degree relative (father) diagnosed with cardiovascular disease at age 62. A baseline lipid panel at your next GP visit is recommended. Results will help calibrate how aggressively the cardiovascular-protective compounds in this stack (Omega-3, CoQ10) should be dosed going forward.
Fasting glucose or HbA1c: Recommended as a baseline given paternal CVD history, even at age 34 with a normal BMI. No urgent concern - this is a preventive data point.
Testosterone (total and free): Optional but useful baseline for a 34-year-old male with fatigue and an energy goal who is beginning Ashwagandha, which may modestly raise testosterone in men with sub-optimal levels. Useful to have a pre-supplementation figure for comparison at 12 weeks.
Ferritin: Persistent fatigue and the mid-afternoon slump you described can reflect low ferritin even when haemoglobin is within the normal laboratory range. Ferritin below 50 µg/L is associated with cognitive symptoms and reduced energy. Your dietary iron intake is adequate for a male omnivore, but testing is the only way to rule this out as a contributing factor. If ferritin is low, iron supplementation would be considered at reassessment.
Lipid panel (total cholesterol, LDL, HDL, triglycerides): First-degree relative (father) diagnosed with cardiovascular disease at age 62. A baseline lipid panel at your next GP visit is recommended. Results will help calibrate how aggressively the cardiovascular-protective compounds in this stack (Omega-3, CoQ10) should be dosed going forward.
Fasting glucose or HbA1c: Recommended as a baseline given paternal CVD history, even at age 34 with a normal BMI. No urgent concern - this is a preventive data point.
Testosterone (total and free): Optional but useful baseline for a 34-year-old male with fatigue and an energy goal who is beginning Ashwagandha, which may modestly raise testosterone in men with sub-optimal levels. Useful to have a pre-supplementation figure for comparison at 12 weeks.
Your Current Supplements: Reviewed
What to keep, what to upgrade, and what to stop
| Supplement | Verdict | Assessment |
|---|---|---|
| Creatine Monohydrate 5g daily | Keep | Continue exactly as you are. Creatine monohydrate at 5g daily is the correct form and dose - the most studied ergogenic compound available. Six months of consistent use means you are in the maintenance phase and will not see a step-change from continuing, but stopping would gradually erode the intramuscular creatine stores you have built. It is not duplicated anywhere in the new stack. Keep taking it on training and non-training days alike. Timing is flexible - it does not need to be pre-workout at maintenance dose. |
| Vitamin C gummies (occasional, 1–2 per week) | Adjust | The intention is right but the execution is not working. Vitamin C taken once or twice a week does not maintain the tissue saturation needed for antioxidant support, stress-related demand, or immune function. Gummy forms also typically deliver low doses with added sugar and inferior bioavailability. The fix is straightforward: switch to a plain ascorbic acid or calcium ascorbate capsule or tablet, 500mg daily with a meal. This is not added as a standalone compound card in the new stack because the dose is modest and the interaction with other compounds is minimal - but consistent daily intake at this dose will meaningfully outperform your current occasional gummy. At the 12-week reassessment, if any immune or skin goals become relevant, Vitamin C can be elevated to a higher dose and formally incorporated into the stack. |
Introduction Schedule
Introduction Schedule
Every compound in the order it is introduced. Full rationale and compound detail follows below.
| Week | Compound | Daily dose | When to take | Tier | Grade |
|---|---|---|---|---|---|
| Already taking | Creatine Monohydrate | 5g | With breakfast or post-workout | Foundation | A |
| Week 1 | Vitamin D3 + K2 (MK-7) | 2,000 IU D3 · 100mcg K2 MK-7 | Breakfast (with fat) | Foundation | A |
| Week 2 | Magnesium Glycinate | 400mg elemental magnesium (as bisglycinate) | Before bed (60 min before sleep) | Foundation | A |
| Week 3 | Omega-3 EPA/DHA | 2g combined EPA+DHA (EPA-dominant 2:1) | Dinner (with fat) | Foundation | A |
| Week 4 | Zinc Bisglycinate | 15mg elemental zinc | Lunch (with food) | Foundation | A |
| Week 5 | Vitamin B Complex (active forms) | 1 capsule comprehensive active B complex | Breakfast (with food) | Targeted | A |
| Week 7 | Ashwagandha (KSM-66) | 300mg KSM-66 extract | Evening (with dinner or 60 min before bed) | Targeted | A |
| Week 9 | L-Theanine | 200mg | Before bed (30–45 min before sleep) | Targeted | A |
| Week 11 | Glycine | 3g | Before bed (30 min before sleep) | Targeted | B |
| Week 13 | Apigenin | 50mg chamomile extract standardised to apigenin | Before bed (30–60 min before sleep) | Targeted | C |
| Week 15 | Lion's Mane (Hericium erinaceus) | 1,000mg fruiting body extract (min 30% beta-glucans) | Breakfast (morning only) | Targeted | B |
| Week 17 | Bacopa Monnieri | 300mg standardised to 55% bacosides | Breakfast (with fat-containing meal) | Targeted | B |
| Week 19 | Rhodiola Rosea | 200mg standardised to 3% rosavins + 1% salidroside | Morning (before or with breakfast - never after midday) | Optimise | B |
| Week 21 | Coenzyme Q10 (Ubiquinol) | 100mg Ubiquinol | Breakfast (with fat - morning only) | Optimise | B |
| Week 23 | Phosphatidylserine | 300mg | Morning or midday (not evening) | Optimise | B |
Daily Supplement Schedule
Daily Supplement Schedule
When to take each compound and why. This is your complete daily protocol once all compounds are introduced.
| Compound | Meal slot | Dose | Reason for timing |
|---|---|---|---|
| Vitamin D3 + K2 (MK-7) | Breakfast | 2,000 IU D3 · 100mcg K2 | Fat-soluble Both D3 and K2 are fat-soluble. Requires at least 10–15g dietary fat for meaningful absorption. Take with your first meal of the day even if breakfast is small. |
| Vitamin B Complex (active forms) | Breakfast | 1 capsule | Stomach protection B vitamins on an empty stomach can cause nausea, particularly at active doses. Morning timing also supports energy metabolism throughout the day. Riboflavin will turn urine bright yellow - this is harmless. |
| Coenzyme Q10 (Ubiquinol) | Breakfast | 100mg Ubiquinol | Fat-soluble Fat-soluble compound. Absorption is significantly improved with dietary fat. Morning timing is important: CoQ10 taken in the evening can cause difficulty falling asleep in some individuals. |
| Lion's Mane (Hericium erinaceus) | Breakfast | 1,000mg fruiting body extract | Timing-dependent Mildly activating. Morning-only to avoid any interference with sleep onset. Pairs naturally with Bacopa in your cognitive stack. |
| Bacopa Monnieri | Breakfast | 300mg (55% bacosides) | Fat-soluble Requires a fat-containing meal for absorption. Taken alongside Lion's Mane to maximise the NGF-stimulation and memory-consolidation synergy between the two compounds. |
| Rhodiola Rosea | Breakfast | 200mg (3% rosavins) | Timing-dependent Stimulating adaptogen. Must be taken before or with breakfast and never after midday. Afternoon or evening dosing consistently disrupts sleep onset in the clinical literature. |
| Creatine Monohydrate | Breakfast or post-workout | 5g | Stomach protection Timing is flexible for creatine - no circadian mechanism. Taking with food reduces the small risk of GI discomfort. Continue your existing routine. |
| Zinc Bisglycinate | Lunch | 15mg elemental zinc | Stomach protection Zinc causes nausea reliably when taken without food, particularly at the start of supplementation. Midday timing also separates it from the morning fat-soluble compounds and avoids competition with Magnesium for absorption at bedtime. |
| Phosphatidylserine | Lunch | 300mg | Timing-dependent Morning or midday only. Phosphatidylserine taken in the evening has been associated with difficulty falling asleep in some individuals, which conflicts directly with your sleep goal. Midday timing also places it proximate to the afternoon performance window you want to protect. |
| Omega-3 EPA/DHA | Dinner | 2g combined EPA+DHA | Fat-soluble Fat-soluble. Dinner is typically your largest meal with the most dietary fat, optimising absorption. Evening timing also separates it from morning fat-soluble compounds so all are not competing for the same absorption window. |
| Ashwagandha (KSM-66) | Evening (with dinner or before bed) | 300mg KSM-66 | Timing-dependent Evening timing is mechanistically important. Ashwagandha works partly by lowering evening cortisol and supporting HPA axis normalisation overnight. This directly addresses the night-waking pattern identified in your sleep profile. |
| Magnesium Glycinate | Before bed | 400mg elemental magnesium (as bisglycinate) | Timing-dependent GABA-A receptor agonism and NMDA modulation. Timing to 60 minutes before sleep onset maximises the relaxation and cortisol-lowering benefit. The glycinate form co-delivers approximately 2.4g glycine, which is additive to your standalone Glycine dose. |
| Glycine | Before bed | 3g | Timing-dependent NMDA receptor modulation reduces core body temperature, facilitating sleep onset and improving deep sleep architecture. Works through a different mechanism than Magnesium Glycinate and Apigenin, making all three complementary. Set at 3g (lower end of range) because Magnesium Glycinate co-delivers approximately 2.4g additional glycine nightly. |
| L-Theanine | Before bed | 200mg | Timing-dependent Alpha-wave promotion and glutamate modulation support sleep onset specifically. For your onset subtype (30–40 minutes to fall asleep), this is the primary targeted compound. Take 30–45 minutes before you intend to be asleep. |
| Apigenin | Before bed | 50mg chamomile extract standardised to apigenin | Timing-dependent Binds GABA-A benzodiazepine site. Improves subjective sleep depth and quality. Complementary mechanism to both Glycine (NMDA) and Magnesium Glycinate (GABA-A + NMDA). Take 30–60 minutes before sleep. |
Fat note
Fat-soluble compounds (marked above) require 10–15g of dietary fat to absorb properly.
Practical equivalents: 1 tablespoon of olive oil, a handful of nuts, half an avocado,
2 tablespoons of nut butter, or a full-fat yoghurt. Given that you often skip breakfast
or have only black coffee, consider adding a small handful of nuts or a drizzle of olive
oil to your morning routine when taking fat-soluble compounds.
Recommended Stack
Foundation
Four compounds selected on Grade A evidence and confirmed relevance to your profile. Each addresses a documented gap: likely Vitamin D deficiency from office-based work and limited sun exposure; magnesium depletion compounded by regular resistance training and stress; cardiovascular family history elevating the priority of Omega-3; and zinc as a cofactor for testosterone, dopamine synthesis, and immune function given your exercise load. These are introduced one per week because they are well tolerated and rapid sequencing is safe. Everything else builds on these.
Vitamin D3 + K2 (MK-7)
Foundation
Grade A
2,000 IU D3 · 100mcg K2 MK-7
Why this compound
You work indoors five days a week and described limited sun exposure. At UK latitude, UVB synthesis is negligible from October through April regardless of time spent outside, and negligible year-round for anyone primarily office-based. Deficiency in the UK working-age male population is common rather than exceptional. No blood test is available, so the dose is set at 2,000 IU - sufficient for a White British male with limited sun exposure, and safe to maintain before results are available. Once you have a 25-OH-D result, the dose can be adjusted upward if needed.
K2 MK-7 is paired for a specific reason: at supplemental D3 doses, calcium absorption increases. Without K2, that calcium can deposit in soft tissue rather than bone. K2 activates osteocalcin and matrix Gla-protein, directing calcium to bone and away from arterial walls. Given your family history of cardiovascular disease, this pairing is particularly relevant. Allow 8–12 weeks for blood levels to move meaningfully. Retest 25-OH-D at your 12-week checkpoint.
K2 MK-7 is paired for a specific reason: at supplemental D3 doses, calcium absorption increases. Without K2, that calcium can deposit in soft tissue rather than bone. K2 activates osteocalcin and matrix Gla-protein, directing calcium to bone and away from arterial walls. Given your family history of cardiovascular disease, this pairing is particularly relevant. Allow 8–12 weeks for blood levels to move meaningfully. Retest 25-OH-D at your 12-week checkpoint.
Safety and watch for
Well tolerated at 2,000 IU. Hypercalcaemia is only a risk above 10,000 IU sustained long-term. GI discomfort is possible if taken without food. If you are not eating breakfast, take with a small amount of fat (a handful of nuts, a drizzle of olive oil) to support absorption. No prescription medications are present, so no drug interaction applies.
Form
Cholecalciferol (D3) + Menaquinone-7 (K2 MK-7)
Daily dose
2,000 IU D3 · 100mcg K2 MK-7
When to take
Breakfast (with fat)
Introduce
Week 1
Evidence grade
A - multiple RCTs and systematic reviews across deficiency correction, immune function, and cardiovascular outcomes
Goals addressed
Deficiency correction · Energy · Immune support · Cardiovascular risk (family history) · Testosterone (if deficient)
Cycling
Continuous - no cycling required
What to look for
Confirm the label shows cholecalciferol (D3, not ergocalciferol D2) and MK-7 specifically (not MK-4 - MK-7 has a significantly longer half-life and superior bone-related efficacy). The two compounds are often sold together in a single capsule at this dose combination.
What to avoid
Ergocalciferol (D2) - inferior conversion to active D3. MK-4 form of K2 - much shorter half-life, requires multiple daily doses to maintain effect. Gummy formats typically contain inadequate K2 doses.
Search: "Vitamin D3 K2 MK-7 2000IU supplement UK"
Magnesium Glycinate
Foundation
Grade A
400mg elemental magnesium (as bisglycinate)
Why this compound
Magnesium sits at the intersection of almost everything relevant to your goals: sleep onset, night waking, stress regulation, energy metabolism, and blood pressure. It is a cofactor in over 300 enzymatic reactions and plays a direct role in GABA-A receptor activation and cortisol modulation - both mechanistically relevant to your sleep subtype (difficulty falling asleep and waking in the night).
You exercise four times a week combining resistance training and cycling. Both forms deplete magnesium through sweat and muscle demand. This elevates your baseline requirement above the general population estimate. Dietary intake from your described diet - moderate nuts and seeds, limited leafy greens - is unlikely to fully compensate.
The glycinate form is chosen specifically over citrate, malate, or oxide. Glycinate crosses the blood-brain barrier more readily than other forms, delivers the additional sleep-supporting amino acid glycine (approximately 2.4g at this dose), and produces significantly less GI discomfort than oxide or citrate - which matters given your stated preference to avoid digestive upset. Most people notice improved sleep onset within 2–3 weeks. Full cortisol-regulatory effects typically consolidate over 6–8 weeks of consistent use. Response varies - some people notice a clear improvement in sleep quality within the first two weeks; others find the effect more gradual.
You exercise four times a week combining resistance training and cycling. Both forms deplete magnesium through sweat and muscle demand. This elevates your baseline requirement above the general population estimate. Dietary intake from your described diet - moderate nuts and seeds, limited leafy greens - is unlikely to fully compensate.
The glycinate form is chosen specifically over citrate, malate, or oxide. Glycinate crosses the blood-brain barrier more readily than other forms, delivers the additional sleep-supporting amino acid glycine (approximately 2.4g at this dose), and produces significantly less GI discomfort than oxide or citrate - which matters given your stated preference to avoid digestive upset. Most people notice improved sleep onset within 2–3 weeks. Full cortisol-regulatory effects typically consolidate over 6–8 weeks of consistent use. Response varies - some people notice a clear improvement in sleep quality within the first two weeks; others find the effect more gradual.
Safety and watch for
The glycinate form is among the best-tolerated magnesium formulations. Loose stools are possible with citrate or oxide at this dose but are uncommon with glycinate. Take with a small amount of water before bed. Do not take in the daytime - daytime magnesium glycinate causes drowsiness in most people. Alcohol on the same evening has an additive sedating effect with magnesium; at your reported 3–4 units per weekend this is low risk, but avoid combining on the same evening.
Form
Magnesium Glycinate (bisglycinate) - not oxide, not citrate
Daily dose
400mg elemental magnesium (as bisglycinate)
When to take
Before bed - 60 minutes before sleep
Introduce
Week 2
Evidence grade
A - multiple RCTs for sleep, blood pressure, and insulin sensitivity
Goals addressed
Sleep onset · Night waking · Stress resilience · Muscle recovery · Energy metabolism
Glycine co-delivery
Approximately 2.4g glycine delivered alongside elemental magnesium at this dose. Additive with standalone Glycine (3g). Total glycine from both sources: approximately 5.4g nightly - well within safe range.
Cycling
Continuous - no cycling required
What to look for
Label must state magnesium bisglycinate or magnesium glycinate. Check the elemental magnesium figure (not total capsule weight) - target 300–400mg elemental. Some products list total compound weight which is higher. Confirm no oxide or citrate is blended in.
What to avoid
Magnesium oxide - under 4% absorption. Magnesium citrate at high doses produces a laxative effect and is not optimal for sleep. Any product listing only total weight without specifying elemental magnesium on the label.
Search: "Magnesium bisglycinate 400mg elemental UK"
Omega-3 EPA/DHA
Foundation
Grade A
2g combined EPA+DHA (EPA-dominant 2:1 ratio)
Why this compound
Your father was diagnosed with cardiovascular disease at 62. This is a first-degree relative with early-to-middle-age CVD onset, which elevates your own long-term cardiovascular risk profile even at 34. Omega-3 EPA/DHA at 2g daily is the most evidence-backed nutritional intervention for cardiovascular risk reduction, operating through triglyceride reduction, anti-inflammatory prostaglandin pathways, and endothelial function.
You eat oily fish once a week. This provides a meaningful but incomplete Omega-3 base - a single serving of salmon delivers approximately 1–2g EPA+DHA, but the benefit is diluted by the ratio of Omega-6 to Omega-3 in a typical omnivore diet with regular white meat and occasional UPFs. Supplementation at 2g bridged the gap reliably.
An EPA-dominant 2:1 ratio is selected because EPA is the primary anti-inflammatory and cardiovascular compound. DHA is important for brain membrane integrity (relevant to your cognition goal) but at lower relative proportion than EPA for your primary cardiovascular and inflammatory priority. Triglyceride-lowering effects are typically measurable at 8–12 weeks. Mood and cognitive effects from DHA tend to build over 3–6 months of consistent use. Response to subjective energy and inflammation markers varies considerably between individuals.
You eat oily fish once a week. This provides a meaningful but incomplete Omega-3 base - a single serving of salmon delivers approximately 1–2g EPA+DHA, but the benefit is diluted by the ratio of Omega-6 to Omega-3 in a typical omnivore diet with regular white meat and occasional UPFs. Supplementation at 2g bridged the gap reliably.
An EPA-dominant 2:1 ratio is selected because EPA is the primary anti-inflammatory and cardiovascular compound. DHA is important for brain membrane integrity (relevant to your cognition goal) but at lower relative proportion than EPA for your primary cardiovascular and inflammatory priority. Triglyceride-lowering effects are typically measurable at 8–12 weeks. Mood and cognitive effects from DHA tend to build over 3–6 months of consistent use. Response to subjective energy and inflammation markers varies considerably between individuals.
Safety and watch for
No prescription medications present, so no anticoagulant interaction applies. Fishy aftertaste is the most common complaint - refrigerating capsules before taking and consuming with food both reduce this significantly. At 2g combined EPA+DHA, mild blood-thinning is within normal physiological range. If you go for surgery at any point, stop Omega-3 two weeks beforehand and inform your surgeon. Alcohol on the same evening as a high-fat meal is not an interaction concern with Omega-3 specifically at your reported intake level.
Form
Triglyceride form preferred (re-esterified TG) - superior absorption over ethyl ester (EE) form
Daily dose
2g combined EPA+DHA - always check the label for the EPA+DHA combined figure, not the total fish oil capsule weight
When to take
Dinner (with fat)
Introduce
Week 3
Evidence grade
A - REDUCE-IT trial (NEJM 2019), VITAL trial (NEJM 2019), multiple cardiovascular and inflammation meta-analyses
Goals addressed
Cardiovascular risk (family history) · Inflammation · Brain health · Mood stability
Cycling
Continuous - no cycling required
What to look for
IFOS (International Fish Oil Standards) certification is the only meaningful purity standard - it independently tests for heavy metals, PCBs, dioxins, and oxidation (TOTOX score). Look for this certification on the label or the brand's website. Confirm the combined EPA+DHA figure on the nutrition panel, not the total omega-3 or total fish oil figure. Triglyceride (TG) form absorbs significantly better than ethyl ester (EE) form.
What to avoid
Products labelled "1,000mg fish oil" without specifying EPA+DHA content - these typically contain only 300mg combined EPA+DHA per capsule, requiring 6–7 capsules daily to reach this dose. Ethyl ester form without enteric coating. Products without third-party purity testing.
Search: "IFOS certified Omega-3 high EPA 2g EPA+DHA triglyceride form UK"
Zinc Bisglycinate
Foundation
Grade A
15mg elemental zinc
Why this compound
Zinc is a cofactor in testosterone synthesis, dopamine production, immune function, and insulin signalling. You exercise regularly with resistance training, which increases zinc losses through sweat. Your diet includes regular eggs and white meat, which provides some dietary zinc, but the absence of shellfish (the most bioavailable source) and moderate legume intake mean dietary zinc is likely adequate but not generous.
For your energy and mental clarity goal, the dopamine synthesis angle is the most directly relevant: zinc is required as a cofactor for the enzyme that converts L-DOPA to dopamine. Without adequate zinc, this pathway is constrained regardless of precursor availability. The B Complex in your Targeted tier also provides B6 P5P, which works synergistically with zinc in the same pathway.
Important note on testosterone: zinc restores normal testosterone production in men who are deficient. No blood test is available, so no deficiency is confirmed. The claim is not that this compound will raise testosterone - it is that if zinc is one of the factors limiting your testosterone production, correcting it will allow that pathway to function normally. The testosterone baseline test recommended in your blood work section is the right way to assess this. Immune and wound-healing effects are typically apparent within 4–6 weeks. Dopamine-pathway effects on energy and focus, if zinc was a limiting factor, may be noticeable within 4–8 weeks. Some people notice no change - in which case zinc levels were likely already adequate.
For your energy and mental clarity goal, the dopamine synthesis angle is the most directly relevant: zinc is required as a cofactor for the enzyme that converts L-DOPA to dopamine. Without adequate zinc, this pathway is constrained regardless of precursor availability. The B Complex in your Targeted tier also provides B6 P5P, which works synergistically with zinc in the same pathway.
Important note on testosterone: zinc restores normal testosterone production in men who are deficient. No blood test is available, so no deficiency is confirmed. The claim is not that this compound will raise testosterone - it is that if zinc is one of the factors limiting your testosterone production, correcting it will allow that pathway to function normally. The testosterone baseline test recommended in your blood work section is the right way to assess this. Immune and wound-healing effects are typically apparent within 4–6 weeks. Dopamine-pathway effects on energy and focus, if zinc was a limiting factor, may be noticeable within 4–8 weeks. Some people notice no change - in which case zinc levels were likely already adequate.
Safety and watch for
Always take with food - zinc on an empty stomach reliably causes nausea, sometimes severe. At 15mg, this is well within the safe range. Prolonged use above 40mg/day depletes copper - at 15mg this does not apply. No copper supplementation is required at this dose. A metallic taste after taking is common and harmless.
Form
Bisglycinate or Picolinate - not oxide, not sulfate
Daily dose
15mg elemental zinc - check the elemental zinc figure on the label, not the total compound weight
When to take
Lunch (with food)
Introduce
Week 4
Evidence grade
A - multiple RCTs for immune function, testosterone restoration in deficiency, dopamine cofactor role
Goals addressed
Energy and mental clarity · Immune function · Testosterone support (if deficient) · Dopamine pathway cofactor
Cycling
Continuous at 15mg - no cycling required
What to look for
Label should state zinc bisglycinate or zinc picolinate with elemental zinc amount clearly listed. Confirm you are hitting 15mg elemental zinc, not 15mg total compound (the compound weight will be higher - typically 80–120mg for bisglycinate).
What to avoid
Zinc oxide - very poor absorption. Zinc sulfate - acceptable absorption but associated with higher nausea incidence. Many supermarket zinc supplements use oxide; this is not a form worth buying.
Search: "Zinc bisglycinate 15mg elemental UK"
Targeted
Seven compounds selected specifically for your ranked goals: the 2–3pm energy slump and mental clarity, two distinct sleep subtypes (onset difficulty and night waking), and stress resilience. These are introduced from Week 5 onward, with a minimum two-week gap between each new compound. This pacing is deliberate: it allows you to identify what is contributing, and means that if any compound causes a side effect, the source is unambiguous. The sleep stack is layered progressively rather than introduced all at once - Magnesium Glycinate from the Foundation tier comes first and addresses both subtypes, with more targeted compounds added as the picture clarifies.
Vitamin B Complex (Active Forms)
Targeted
Grade A
1 capsule comprehensive active B complex daily
Why this compound
The 2–3pm energy slump you described - reliable, daily, and worsened by caffeine-chasing - is a classic presentation of suboptimal B vitamin status rather than a sleep problem in isolation. B vitamins are not a stimulant. They are the rate-limiting cofactors in the pathways that convert food into usable cellular energy (ATP). Without adequate B2, B3, and B5, these pathways run below capacity regardless of how much you eat or sleep.
B5 (pantothenic acid) is specifically critical for adrenal cortisol pathway function. Under moderate-to-high work stress, B5 demand increases. B6 in P5P form is the cofactor for dopamine and serotonin synthesis - both directly relevant to afternoon focus and mood stability. B9 in methylfolate form (not folic acid) bypasses the MTHFR conversion step; since your MTHFR status is unknown, this is the more reliably available form regardless.
Your diet as described - skipping breakfast, variable food quality, regular refined carbs and occasional UPFs - is not a diet that guarantees B vitamin adequacy. Active B complexes correct this more precisely than food-first approaches when meal quality is inconsistent. Energy pathway improvement is typically noticeable within 2–4 weeks. Urine will turn bright yellow from riboflavin (B2) - this is completely harmless and expected. Some people notice improved mental clarity and mood within the first week; others notice nothing for several weeks.
B5 (pantothenic acid) is specifically critical for adrenal cortisol pathway function. Under moderate-to-high work stress, B5 demand increases. B6 in P5P form is the cofactor for dopamine and serotonin synthesis - both directly relevant to afternoon focus and mood stability. B9 in methylfolate form (not folic acid) bypasses the MTHFR conversion step; since your MTHFR status is unknown, this is the more reliably available form regardless.
Your diet as described - skipping breakfast, variable food quality, regular refined carbs and occasional UPFs - is not a diet that guarantees B vitamin adequacy. Active B complexes correct this more precisely than food-first approaches when meal quality is inconsistent. Energy pathway improvement is typically noticeable within 2–4 weeks. Urine will turn bright yellow from riboflavin (B2) - this is completely harmless and expected. Some people notice improved mental clarity and mood within the first week; others notice nothing for several weeks.
Safety and watch for
Bright yellow urine from riboflavin is normal and harmless. Nausea is possible if taken on an empty stomach - take with food. High-dose isolated niacin (B3) can cause a flushing sensation, but this only occurs with high-dose standalone niacin, not in a balanced B complex. Do not take a B complex alongside high-dose standalone B6 (P5P) - combined B6 exceeding 50mg/day over extended periods is associated with peripheral sensory neuropathy, which is reversible on cessation. Your B complex alone stays well within this limit; no standalone B6 is in this stack.
Key active forms required
B6 as P5P (pyridoxal-5-phosphate), B9 as methylfolate (5-MTHF), B12 as methylcobalamin - not cyanocobalamin
Daily dose
1 capsule per label instructions - confirm active forms on the label before purchasing
When to take
Breakfast (with food)
Introduce
Week 5
Evidence grade
A for deficiency correction and energy metabolism; B for stress and mood outcomes
Goals addressed
Energy and mental clarity · Afternoon slump · Stress resilience · Dopamine and serotonin synthesis cofactors · Homocysteine management (cardiovascular)
Cycling
Continuous - no cycling required
What to look for
The three active forms are the distinguishing features of a quality B complex: B6 listed as pyridoxal-5-phosphate (P5P), B9 listed as methylfolate or 5-MTHF (not folic acid), and B12 listed as methylcobalamin (not cyanocobalamin). These active forms are absorbed and used directly without requiring conversion steps. Many mainstream B complexes use the cheaper inactive forms.
What to avoid
B complexes using folic acid (not methylfolate), cyanocobalamin (not methylcobalamin), and pyridoxine HCl (not P5P). These are conversion-dependent forms that work less reliably in a meaningful proportion of the population. Budget supermarket B complexes nearly always use these inactive forms.
Search: "Active B complex P5P methylfolate methylcobalamin UK"
Ashwagandha (KSM-66)
Targeted
Grade A
300mg KSM-66 extract
GP Review Recommended: Thyroid Function Tests
Ashwagandha KSM-66 can alter thyroid hormone levels (TSH, T3, T4). If your GP orders thyroid function tests at any point while you are taking this supplement, inform them you are taking Ashwagandha KSM-66 300mg before the results are interpreted. Test values may be affected even in the absence of a thyroid condition.
Why this compound
Your sleep problem has two distinct components: difficulty falling asleep and waking once or twice in the night. These are different mechanisms. The onset problem (lying awake 30–40 minutes) is primarily a nervous system arousal issue, addressed most directly by L-Theanine, Glycine, and Apigenin later in the schedule. The maintenance problem (waking in the night) is primarily a cortisol and HPA axis dysregulation issue - cortisol levels that remain elevated or spike too early in the morning cause arousal at 2–4am. Ashwagandha is the most evidence-backed compound for this specific mechanism.
KSM-66 at 300–600mg has been shown in multiple RCTs to reduce morning serum cortisol, improve subjective sleep quality scores, and reduce time awake after sleep onset. The Chandrasekhar 2012 and Langade 2019 trials are the most cited. KSM-66 is the root-only extract standardised to the concentrations used in these trials - raw powder and non-standardised extracts are not equivalent and should not be substituted.
Ashwagandha is started at 300mg (lower end of the evidence range) given your side effect preference to avoid digestive upset. The dose can be raised to 600mg at your 12-week reassessment if the 300mg dose has been well tolerated and the effect is partial. Cortisol-related sleep improvements typically appear at 4–8 weeks of consistent evening dosing. Stress resilience changes are often reported at 2–4 weeks. Response varies - some people notice a meaningful shift in their night-waking pattern within three weeks; others require 8 weeks before the effect consolidates. Reassess at 8 weeks before adjusting the dose.
KSM-66 at 300–600mg has been shown in multiple RCTs to reduce morning serum cortisol, improve subjective sleep quality scores, and reduce time awake after sleep onset. The Chandrasekhar 2012 and Langade 2019 trials are the most cited. KSM-66 is the root-only extract standardised to the concentrations used in these trials - raw powder and non-standardised extracts are not equivalent and should not be substituted.
Ashwagandha is started at 300mg (lower end of the evidence range) given your side effect preference to avoid digestive upset. The dose can be raised to 600mg at your 12-week reassessment if the 300mg dose has been well tolerated and the effect is partial. Cortisol-related sleep improvements typically appear at 4–8 weeks of consistent evening dosing. Stress resilience changes are often reported at 2–4 weeks. Response varies - some people notice a meaningful shift in their night-waking pattern within three weeks; others require 8 weeks before the effect consolidates. Reassess at 8 weeks before adjusting the dose.
Safety and watch for
Vivid dreams are common in the first 1–2 weeks of use, particularly at the evening dose timing. These typically settle without any change to the protocol. Mild GI discomfort on initiation is possible - taking it with dinner rather than on an empty stomach reduces this. Avoid combining with alcohol on the same evening: additive sedating effect at your reported intake level is mild but worth noting.
Ashwagandha can alter thyroid hormone levels (TSH, T3, T4). No thyroid condition is present in your profile and no thyroid medication is listed. If you develop any unusual symptoms (extreme fatigue, palpitations, unexplained weight change) within the first 8 weeks, flag to your GP and mention this supplement by name.
Reassessment note: Long-term safety data supports continuous use up to 12 months. If you use Ashwagandha for more than 8 consecutive weeks and decide to stop, taper over 1–2 weeks rather than stopping abruptly - rebound anxiety can occur with sudden cessation.
Ashwagandha can alter thyroid hormone levels (TSH, T3, T4). No thyroid condition is present in your profile and no thyroid medication is listed. If you develop any unusual symptoms (extreme fatigue, palpitations, unexplained weight change) within the first 8 weeks, flag to your GP and mention this supplement by name.
Reassessment note: Long-term safety data supports continuous use up to 12 months. If you use Ashwagandha for more than 8 consecutive weeks and decide to stop, taper over 1–2 weeks rather than stopping abruptly - rebound anxiety can occur with sudden cessation.
Form
KSM-66 root extract only - Sensoril (leaf+root) is also acceptable at 125–250mg. Raw powder is not equivalent.
Daily dose
300mg KSM-66 (can increase to 600mg at 12-week reassessment if partial response)
When to take
Evening - with dinner or 60 minutes before bed
Introduce
Week 7 (minimum 2 weeks after B Complex is established)
Evidence grade
A for cortisol and stress; B for sleep quality and testosterone
Goals addressed
Night waking · Stress resilience · HPA axis regulation · Testosterone support
Cycling
Up to 12 months continuous. Taper over 1–2 weeks if stopping after 8+ weeks of use. Annual reassessment.
What to look for
The label must state KSM-66 or Sensoril by name - these are trademarked, standardised extracts used in clinical trials. KSM-66 is the root-only extract. Both are distinct from generic ashwagandha root powder. Confirm the dose per capsule matches: 300mg KSM-66.
What to avoid
Generic "ashwagandha root powder" products without KSM-66 or Sensoril designation - these are not equivalent to the extracts used in trials and standardisation varies significantly. Products labelling only "withania somnifera extract" without the standardised extract name.
Search: "Ashwagandha KSM-66 300mg UK"
L-Theanine
Targeted
Grade A
200mg
Why this compound
Your primary sleep onset problem - lying awake for 30–40 minutes - is most consistent with a hyperarousal pattern: the brain failing to downshift from the task-activated state of the day into sleep-compatible alpha-wave activity. L-Theanine is the most well-supported single compound for this specific mechanism.
L-Theanine promotes alpha-wave generation (the relaxed but alert state also seen in meditation), reduces glutamatergic excitation, and lowers subjective mental chatter without causing sedation at typical doses. The distinction matters: this compound does not knock you out - it removes the neural noise that prevents natural sleep onset. It is not addictive and does not disrupt sleep architecture.
There is a secondary relevance here. You mentioned wanting to reduce reliance on caffeine for afternoon focus. L-Theanine at 100mg alongside your existing morning coffee produces a smoother, more sustained alertness curve - the research on the L-Theanine + caffeine combination (4:1 theanine:caffeine ratio) is among the most replicated findings in the nootropic literature. This is noted as a potential daytime use case as your stack matures, though the primary dose in this stack is the 200mg evening dose for sleep onset. Sleep onset improvement is typically noticed within 3–7 days. Response varies - some people find it substantially reduces time-to-sleep within the first week; others notice a more modest effect or need 2–3 weeks for it to become consistent. It is one of the faster-acting compounds in this stack.
L-Theanine promotes alpha-wave generation (the relaxed but alert state also seen in meditation), reduces glutamatergic excitation, and lowers subjective mental chatter without causing sedation at typical doses. The distinction matters: this compound does not knock you out - it removes the neural noise that prevents natural sleep onset. It is not addictive and does not disrupt sleep architecture.
There is a secondary relevance here. You mentioned wanting to reduce reliance on caffeine for afternoon focus. L-Theanine at 100mg alongside your existing morning coffee produces a smoother, more sustained alertness curve - the research on the L-Theanine + caffeine combination (4:1 theanine:caffeine ratio) is among the most replicated findings in the nootropic literature. This is noted as a potential daytime use case as your stack matures, though the primary dose in this stack is the 200mg evening dose for sleep onset. Sleep onset improvement is typically noticed within 3–7 days. Response varies - some people find it substantially reduces time-to-sleep within the first week; others notice a more modest effect or need 2–3 weeks for it to become consistent. It is one of the faster-acting compounds in this stack.
Safety and watch for
Exceptionally well tolerated. No known serious side effects at standard doses. Avoid combining with alcohol on the same evening: mild additive sedating effect. At high doses (above 400mg) combined with other sedating compounds (Magnesium Glycinate, Ashwagandha, Apigenin, Glycine), drowsiness is additive - the doses in this stack are calibrated to work together without excessive sedation, but be aware of the combined picture.
Form
L-Theanine - Suntheanine is the branded form used in most trials (pure L-isomer); generic L-Theanine from reputable suppliers is equivalent
Daily dose
200mg before bed
When to take
Before bed - 30 to 45 minutes before intended sleep
Introduce
Week 9
Evidence grade
A for anxiety and sleep onset; B for cognitive performance
Goals addressed
Sleep onset · Stress resilience · Mental calm · Cognitive focus (secondary)
Cycling
Continuous - no cycling required
Sourcing
L-Theanine has a small quality gap. Suntheanine is the branded L-isomer form used in most clinical trials, but high-quality generic L-Theanine from reputable supplement suppliers is equivalent. Confirm the label states L-Theanine (not DL-Theanine, which contains the inactive D-isomer). 200mg per capsule is the most common dose available.
Search term: "L-Theanine 200mg UK"
Search term: "L-Theanine 200mg UK"
Glycine
Targeted
Grade B
3g before sleep
Why this compound
Glycine addresses a specific and underappreciated mechanism in sleep quality: core body temperature reduction. Falling asleep requires core body temperature to drop by approximately 1–1.5°C. Glycine facilitates this through peripheral vasodilation - it effectively opens up blood flow to the hands and feet, allowing heat to dissipate from the body's core more rapidly. This accelerates sleep onset and improves the proportion of slow-wave (deep) sleep.
For you, this compound is relevant to both sleep subtypes. For onset (lying awake 30–40 minutes), the thermoregulatory mechanism supports the same goal as L-Theanine but through a completely different pathway - making the two genuinely additive rather than redundant. For sleep maintenance, improved deep sleep architecture means the second half of the night is more restorative, which may reduce the waking events.
The dose is set at 3g rather than the upper end of the range (5g). Your Magnesium Glycinate (400mg elemental) co-delivers approximately 2.4g of glycine through the glycinate chelate. Combined total glycine from both compounds is approximately 5.4g nightly, which is within the effective and safe range. The 3g standalone dose is calibrated to keep the total contribution reasonable. Sleep onset and sleep quality improvements from glycine are typically noticed within 1–3 nights in people who respond. The RCT evidence (Yamadera 2007) showed effects measurable at the first assessment point. That said, the evidence base is smaller than Grade A compounds - one primary RCT, small sample size. Grade B classification is appropriate but it is worth setting realistic expectations: not everyone responds meaningfully to glycine.
For you, this compound is relevant to both sleep subtypes. For onset (lying awake 30–40 minutes), the thermoregulatory mechanism supports the same goal as L-Theanine but through a completely different pathway - making the two genuinely additive rather than redundant. For sleep maintenance, improved deep sleep architecture means the second half of the night is more restorative, which may reduce the waking events.
The dose is set at 3g rather than the upper end of the range (5g). Your Magnesium Glycinate (400mg elemental) co-delivers approximately 2.4g of glycine through the glycinate chelate. Combined total glycine from both compounds is approximately 5.4g nightly, which is within the effective and safe range. The 3g standalone dose is calibrated to keep the total contribution reasonable. Sleep onset and sleep quality improvements from glycine are typically noticed within 1–3 nights in people who respond. The RCT evidence (Yamadera 2007) showed effects measurable at the first assessment point. That said, the evidence base is smaller than Grade A compounds - one primary RCT, small sample size. Grade B classification is appropriate but it is worth setting realistic expectations: not everyone responds meaningfully to glycine.
Safety and watch for
Among the best-tolerated compounds in this stack. Glycine is a non-essential amino acid present in significant quantities in food. No known serious adverse effects at these doses. Mild sedation is the intended effect - take 30 minutes before sleep, not during the day. Avoid combining with alcohol on the same evening: additive sedating effect, particularly when combined with the other bedtime compounds already present.
Form
Pure glycine powder or capsules - no specific branded form required
Daily dose
3g - dosed at the lower end because Magnesium Glycinate co-delivers approximately 2.4g additional glycine nightly (combined total approximately 5.4g)
When to take
Before bed - 30 minutes before sleep
Introduce
Week 11
Evidence grade
B for sleep quality; C for longevity and methylation support
Goals addressed
Sleep onset · Sleep quality and depth · Recovery
Cycling
Continuous - no cycling required
Sourcing
Glycine is widely available and has no meaningful quality gap between suppliers at this dose. Pure glycine powder is cost-effective and easily mixed into a small amount of water before bed. Capsule format is also available for convenience. No specific branded form is required.
Search term: "Glycine powder 500g pure amino acid UK" or "Glycine 1000mg capsules UK"
Search term: "Glycine powder 500g pure amino acid UK" or "Glycine 1000mg capsules UK"
Apigenin
Targeted
Grade C
50mg chamomile extract standardised to apigenin
Why this compound
Apigenin is the third mechanism in the bedtime sleep stack and works differently from both Magnesium Glycinate and Glycine. It binds to the benzodiazepine site on GABA-A receptors - the same molecular target as pharmaceutical sleep medications, but with considerably lower binding affinity and without the dependency, rebound insomnia, or next-day impairment associated with pharmaceutical benzodiazepines.
The clinical evidence base is primarily chamomile extract RCTs (apigenin being chamomile's primary bioactive compound). Results show modest but consistent improvements in subjective sleep quality and daytime functioning rather than dramatic effects on sleep latency. This is a Grade C compound - the human trial data is real, the mechanism is well-characterised, but the sample sizes are small and the effects are modest. It is included because: (a) the mechanism is genuinely additive to Glycine and Magnesium, (b) the safety profile is excellent, and (c) the compound cost is low relative to the potential marginal benefit.
This is the last compound to be added to the sleep stack, because it is the weakest evidence tier. If the Foundation and earlier Targeted compounds have already resolved the sleep problem by Week 13, there is no need to add it. Effects, if present, are typically noticed within 1–2 weeks of consistent use. As a Grade C compound, honest expectation-setting is owed: some people notice a clear improvement in sleep depth; others notice nothing. The compound is worth trying at this stage precisely because the sleep stack will have been running for 11 weeks by the time you add it - if sleep has already improved, you can defer this compound entirely.
The clinical evidence base is primarily chamomile extract RCTs (apigenin being chamomile's primary bioactive compound). Results show modest but consistent improvements in subjective sleep quality and daytime functioning rather than dramatic effects on sleep latency. This is a Grade C compound - the human trial data is real, the mechanism is well-characterised, but the sample sizes are small and the effects are modest. It is included because: (a) the mechanism is genuinely additive to Glycine and Magnesium, (b) the safety profile is excellent, and (c) the compound cost is low relative to the potential marginal benefit.
This is the last compound to be added to the sleep stack, because it is the weakest evidence tier. If the Foundation and earlier Targeted compounds have already resolved the sleep problem by Week 13, there is no need to add it. Effects, if present, are typically noticed within 1–2 weeks of consistent use. As a Grade C compound, honest expectation-setting is owed: some people notice a clear improvement in sleep depth; others notice nothing. The compound is worth trying at this stage precisely because the sleep stack will have been running for 11 weeks by the time you add it - if sleep has already improved, you can defer this compound entirely.
Safety and watch for
Well tolerated. Drowsiness is expected and intended - do not drive or operate machinery after taking. Take 30–60 minutes before bed. The GABA-A mechanism means additive sedation applies with other compounds in your bedtime stack (Magnesium Glycinate, L-Theanine, Glycine) - the doses are calibrated to be complementary rather than excessive, but be alert to any next-morning grogginess in the first week, particularly if you are consuming alcohol on the same evening.
Form
Chamomile extract standardised to apigenin content - 50mg apigenin-equivalent dose. Confirm apigenin standardisation on the label.
Daily dose
50mg chamomile extract standardised to apigenin
When to take
Before bed - 30 to 60 minutes before sleep
Introduce
Week 13 - only if sleep has not already resolved satisfactorily with earlier compounds
Evidence grade
C - chamomile RCTs show modest consistent effects; mechanism well characterised but human data limited in scale
Goals addressed
Sleep quality and depth · Sleep onset (secondary)
Cycling
Continuous acceptable at this dose - no cycling required
Sourcing
Look for chamomile extract with apigenin content stated on the label. The active dose is the apigenin standardisation, not the total chamomile weight. Some products list high chamomile extract weights with no apigenin standardisation - these are not equivalent. Confirm the product specifies apigenin content or standardisation percentage.
Search term: "Apigenin 50mg chamomile extract standardised UK"
Search term: "Apigenin 50mg chamomile extract standardised UK"
Lion's Mane (Hericium erinaceus)
Targeted
Grade B
1,000mg fruiting body extract (minimum 30% beta-glucans)
Why this compound
Your first-ranked goal is energy and mental clarity, with a specific complaint of feeling mentally drained by mid-afternoon. This is a cognitive endurance problem as much as an energy problem - the brain's capacity to sustain focus and resist mental fatigue over a long working day. Lion's Mane addresses this through a distinct mechanism from any other compound in this stack: NGF (nerve growth factor) stimulation.
Hericenones (found in the fruiting body) and erinacines (found in the mycelium) stimulate the brain's own production of NGF, which supports neuronal maintenance, plasticity, and the integrity of the cholinergic pathways most directly associated with sustained attention and working memory. This is not an acute stimulant effect - it is a structural, longer-term change in the brain's capacity to do cognitive work.
This compound is most synergistic with Bacopa Monnieri (introduced two weeks later), which addresses the memory consolidation and processing speed dimension through acetylcholinergic mechanisms. The combination covers NGF-stimulation and cholinergic function - the best cognitive synergy pair in the evidence base.
Fruiting body extract only. Mycelium-on-grain products - which dominate Amazon listings - typically contain more grain starch than active mushroom content. The standardisation to minimum 30% beta-glucans is the meaningful quality marker. Lion's Mane requires 4–8 weeks of consistent use before cognitive effects become noticeable. NGF upregulation is a gradual structural process. Do not assess effectiveness before 6 weeks. Some people notice nothing until 10–12 weeks - this is consistent with the mechanism.
Hericenones (found in the fruiting body) and erinacines (found in the mycelium) stimulate the brain's own production of NGF, which supports neuronal maintenance, plasticity, and the integrity of the cholinergic pathways most directly associated with sustained attention and working memory. This is not an acute stimulant effect - it is a structural, longer-term change in the brain's capacity to do cognitive work.
This compound is most synergistic with Bacopa Monnieri (introduced two weeks later), which addresses the memory consolidation and processing speed dimension through acetylcholinergic mechanisms. The combination covers NGF-stimulation and cholinergic function - the best cognitive synergy pair in the evidence base.
Fruiting body extract only. Mycelium-on-grain products - which dominate Amazon listings - typically contain more grain starch than active mushroom content. The standardisation to minimum 30% beta-glucans is the meaningful quality marker. Lion's Mane requires 4–8 weeks of consistent use before cognitive effects become noticeable. NGF upregulation is a gradual structural process. Do not assess effectiveness before 6 weeks. Some people notice nothing until 10–12 weeks - this is consistent with the mechanism.
Safety and watch for
Generally well tolerated. Mild GI discomfort is possible on initiation - taking with food reduces this. In rare cases, skin rash has been reported; discontinue immediately if this occurs and do not reintroduce. Mildly activating - morning use only. Do not take in the afternoon or evening as it may contribute to sleep onset difficulty (counterproductive given your sleep goal). No mushroom allergy is listed in your intake.
Form
Fruiting body extract, standardised to minimum 30% beta-glucans. Hericenone content specification is a further positive quality marker if available on the label.
Daily dose
1,000mg fruiting body extract
When to take
Breakfast - morning only
Introduce
Week 15
Evidence grade
B - Mori 2009 RCT in mild cognitive impairment, Docherty 2023 Nutrients cognitive function RCT
Goals addressed
Mental clarity and cognitive endurance · Sustained afternoon focus · Neuroprotection (background longevity goal)
Cycling
Continuous acceptable - no cycling protocol required
What to look for
Label must state "fruiting body extract" and list beta-glucan content - minimum 30%. Hericenone or erinacine content specified is an additional positive quality marker. Hot water extraction is the standard processing method for mushroom beta-glucans.
What to avoid
Products labelled "mycelium on grain" or "myceliated grain" - these are fermented grain products with variable and often negligible mushroom content. Products without beta-glucan standardisation on the label. The majority of Lion's Mane products on major retail platforms use mycelium-on-grain.
Search: "Lion's Mane fruiting body extract beta-glucan standardised UK"
Bacopa Monnieri
Targeted
Grade B
300mg standardised to 55% bacosides
Why this compound
Bacopa Monnieri addresses the cognitive endurance and working memory dimensions of your first-ranked goal, working through acetylcholinergic mechanisms that are complementary to and synergistic with Lion's Mane's NGF pathway. The specific effects documented across multiple RCTs are: improved verbal learning speed, working memory capacity, and cognitive processing accuracy under conditions of mental load. These effects are particularly relevant to knowledge work sustained across a long day.
Bacopa is also an adaptogen with mild anxiolytic properties - it reduces background anxiety and cognitive noise through mechanisms partially overlapping with Ashwagandha's cortisol pathway, but acting more directly on cholinergic and serotonergic signalling. For stress resilience (your third goal), this is a secondary benefit rather than the primary reason for its inclusion.
One point that must be stated plainly about this compound: the onset time is 8–12 weeks minimum. This is not a typical supplement timeline - it is a reflection of how acetylcholinergic neuroplasticity works. Do not assess Bacopa before week 27 (10 weeks after introduction at Week 17). Assessing it at 4 weeks and concluding it does not work is a common and understandable error, but it would be the wrong conclusion. Meaningful cognitive effects typically emerge at 8–12 weeks of consistent daily use. The 8-week trial by Stough 2001 and Kongkeaw 2014 meta-analysis both confirm this onset trajectory. Initial weeks often involve no noticeable effect, occasionally mild fatigue or brain fog (which typically resolves by week 4). Do not assess before week 10 at the earliest.
Bacopa is also an adaptogen with mild anxiolytic properties - it reduces background anxiety and cognitive noise through mechanisms partially overlapping with Ashwagandha's cortisol pathway, but acting more directly on cholinergic and serotonergic signalling. For stress resilience (your third goal), this is a secondary benefit rather than the primary reason for its inclusion.
One point that must be stated plainly about this compound: the onset time is 8–12 weeks minimum. This is not a typical supplement timeline - it is a reflection of how acetylcholinergic neuroplasticity works. Do not assess Bacopa before week 27 (10 weeks after introduction at Week 17). Assessing it at 4 weeks and concluding it does not work is a common and understandable error, but it would be the wrong conclusion. Meaningful cognitive effects typically emerge at 8–12 weeks of consistent daily use. The 8-week trial by Stough 2001 and Kongkeaw 2014 meta-analysis both confirm this onset trajectory. Initial weeks often involve no noticeable effect, occasionally mild fatigue or brain fog (which typically resolves by week 4). Do not assess before week 10 at the earliest.
Safety and watch for
GI discomfort and nausea are common on initiation if taken without food - always take with a fat-containing meal, which also improves absorption. Mild fatigue or brain fog in the first 2–4 weeks is documented and typically self-resolving. Dry mouth is occasionally reported. These early-week effects are not a reason to stop - they generally resolve completely before the therapeutic window opens at 8 weeks.
Form
Standardised extract, 55% bacosides - this standardisation is the quality benchmark used in trials
Daily dose
300mg standardised to 55% bacosides
When to take
Breakfast (with fat-containing meal)
Introduce
Week 17 - assess effectiveness no earlier than Week 27 (10 weeks post-introduction)
Evidence grade
B - Kongkeaw 2014 meta-analysis (J Ethnopharmacol), multiple independent RCTs for memory and cognitive processing
Goals addressed
Mental clarity · Working memory · Cognitive processing speed · Mild stress resilience
Cycling
Continuous - no cycling required
What to look for
Bacopa extract standardised to 55% bacosides - this must be on the label. The bacoside percentage is the only meaningful quality marker. 300mg of unstandardised Bacopa powder is not equivalent to 300mg of 55% bacosides extract. Brahmi is an alternative name for the same plant.
What to avoid
Unstandardised Bacopa root powder without bacoside percentage stated. Products with bacoside percentages below 20% - these are common in value-market products and will not reproduce trial results at the same capsule dose.
Search: "Bacopa Monnieri 300mg 55% bacosides standardised UK"
Optimise
Three compounds added once the Foundation and Targeted stack is established and tolerated. Rhodiola addresses the stress resilience and afternoon mental fatigue goals with a different mechanism than Ashwagandha - stimulating where Ashwagandha is calming, and introduced only after Ashwagandha is well established (minimum 12 weeks between the two adaptogens). CoQ10 is included for your cardiovascular family history and mitochondrial energy production: at 34 it is an earlier investment than most clients make, but the paternal CVD history justifies it. Phosphatidylserine is the most targeted cognitive compound in the stack for the afternoon slump specifically, modulating cortisol response to cognitive load. All three carry Grade B evidence. Introduce one per two weeks from Week 19 onward.
Rhodiola Rosea
Optimise
Grade B
200mg standardised to 3% rosavins + 1% salidroside
Why this compound
Rhodiola is the second adaptogen in this stack and is deliberately sequenced at Week 19, a minimum of 12 weeks after Ashwagandha is introduced at Week 7. This stagger is mandatory: the two adaptogens have overlapping side effect profiles and introducing them within 4 weeks of each other makes attribution of any effect or side effect impossible.
Where Ashwagandha is calming and works primarily through HPA axis cortisol reduction, Rhodiola is mildly activating and works primarily on mental fatigue - specifically on the subjective experience of effort cost during sustained cognitive or physical work. The Darbinyan 2000 and Shevtsov 2003 RCTs show reductions in mental fatigue scores and improved performance on sustained attention tasks. For the 2–3pm cognitive drain you described, Rhodiola taken in the morning is the most directly targeted single compound in this stack.
The dose is set at 200mg (lower end of the evidence range) for two reasons: first, your side effect priority to avoid sleep disruption (Rhodiola taken at higher doses or later in the day is reliably associated with insomnia in the literature); second, your stress profile is moderate rather than burnout-level, and lower doses are sufficient for stress resilience at this severity. If the 200mg dose is well tolerated and the effect is partial at 12 weeks, increase to 400mg. Mental fatigue effects are typically noticeable within 1–2 weeks of consistent morning use. Stress resilience effects build over 4–6 weeks. Response varies: some people find Rhodiola is their most impactful compound; others notice little. If after 6 weeks at 200mg the effect is absent, try 400mg for a further 6 weeks before concluding non-response.
Where Ashwagandha is calming and works primarily through HPA axis cortisol reduction, Rhodiola is mildly activating and works primarily on mental fatigue - specifically on the subjective experience of effort cost during sustained cognitive or physical work. The Darbinyan 2000 and Shevtsov 2003 RCTs show reductions in mental fatigue scores and improved performance on sustained attention tasks. For the 2–3pm cognitive drain you described, Rhodiola taken in the morning is the most directly targeted single compound in this stack.
The dose is set at 200mg (lower end of the evidence range) for two reasons: first, your side effect priority to avoid sleep disruption (Rhodiola taken at higher doses or later in the day is reliably associated with insomnia in the literature); second, your stress profile is moderate rather than burnout-level, and lower doses are sufficient for stress resilience at this severity. If the 200mg dose is well tolerated and the effect is partial at 12 weeks, increase to 400mg. Mental fatigue effects are typically noticeable within 1–2 weeks of consistent morning use. Stress resilience effects build over 4–6 weeks. Response varies: some people find Rhodiola is their most impactful compound; others notice little. If after 6 weeks at 200mg the effect is absent, try 400mg for a further 6 weeks before concluding non-response.
Safety and watch for
Rhodiola can worsen anxiety in anxiety-prone individuals. Your stress profile is moderate, not anxiety-dominant, and no anxiety diagnosis is present - but be alert to increased restlessness or agitation in the first two weeks and reduce the dose or stop if this occurs. Insomnia is the most commonly reported side effect with suboptimal timing: morning-only dosing is non-negotiable for this compound. Do not take after midday under any circumstances.
Rhodiola should be cycled: 12 weeks on, 4 weeks off. At the 12-week checkpoint in your Reassessment Framework, this is a natural review point. Avoid combining with alcohol on the same evening as the morning dose has long cleared - no interaction concern in your case at 3–4 units per weekend.
Rhodiola should be cycled: 12 weeks on, 4 weeks off. At the 12-week checkpoint in your Reassessment Framework, this is a natural review point. Avoid combining with alcohol on the same evening as the morning dose has long cleared - no interaction concern in your case at 3–4 units per weekend.
Form
Standardised extract - 3% rosavins + 1% salidroside. Both markers must be on the label. Generic Rhodiola without standardisation may deliver highly variable active content.
Daily dose
200mg (increase to 400mg at 12-week review if partial response)
When to take
Morning - before or with breakfast. Never after midday.
Introduce
Week 19 - minimum 12 weeks after Ashwagandha introduction
Evidence grade
B - multiple RCTs for mental fatigue and endurance; B for exercise performance
Goals addressed
Mental fatigue and afternoon slump · Stress resilience · Cognitive endurance · Athletic performance (cycling)
Cycling
12 weeks on, 4 weeks off. Do not use continuously without cycling.
What to look for
Both standardisation markers must be on the label: 3% rosavins AND 1% salidroside. These are the two active compound classes from different biosynthetic pathways; a product standardised only for rosavins or only for salidroside is not equivalent to the dual-standardised extracts used in trials.
What to avoid
Unstandardised Rhodiola root powder. Products standardised for only one marker. High-stimulant combination products that include Rhodiola alongside caffeine, ginseng, or other stimulants - these are not appropriate for your sleep goals.
Search: "Rhodiola Rosea 200mg 3% rosavins 1% salidroside UK"
Coenzyme Q10 (Ubiquinol)
Optimise
Grade B
100mg Ubiquinol
Why this compound
CoQ10 is included primarily because of your paternal family history of cardiovascular disease. CoQ10 is an essential component of the mitochondrial electron transport chain, particularly in cardiac muscle cells, which have the highest mitochondrial density of any tissue in the body. It also functions as a fat-soluble antioxidant within mitochondrial membranes, reducing oxidative damage to the cardiovascular system. The Q-SYMBIO trial (Mortensen 2014, JACC Heart Failure) is the landmark study; CoQ10 at 300mg reduced major cardiovascular events and mortality in heart failure patients. At 34, the goal is prevention and baseline optimisation, not treatment, so a lower dose of 100mg is appropriate.
The secondary relevance is energy production. CoQ10 is the rate-limiting cofactor for mitochondrial ATP synthesis. At 34 with no statin use, CoQ10 levels are unlikely to be severely depleted, but regular high-intensity exercise (cycling + resistance training) increases mitochondrial demand. The afternoon energy slump may have a partial mitochondrial component, and CoQ10 addresses this from a different angle than B Complex (substrate availability) or Rhodiola (fatigue perception).
Ubiquinol specifically (the reduced QH form) is required. The conversion from ubiquinone to ubiquinol becomes progressively less efficient from around age 30 onward. At 34 this is early but not premature to switch. Kaneka QH is the clinically studied brand. Energy effects, if present, are typically noticed within 4–8 weeks. Cardiovascular benefits operate over years of consistent use rather than weeks - this is a long-term investment compound. Some people notice no subjective change while still accruing the relevant cardiovascular antioxidant benefit.
The secondary relevance is energy production. CoQ10 is the rate-limiting cofactor for mitochondrial ATP synthesis. At 34 with no statin use, CoQ10 levels are unlikely to be severely depleted, but regular high-intensity exercise (cycling + resistance training) increases mitochondrial demand. The afternoon energy slump may have a partial mitochondrial component, and CoQ10 addresses this from a different angle than B Complex (substrate availability) or Rhodiola (fatigue perception).
Ubiquinol specifically (the reduced QH form) is required. The conversion from ubiquinone to ubiquinol becomes progressively less efficient from around age 30 onward. At 34 this is early but not premature to switch. Kaneka QH is the clinically studied brand. Energy effects, if present, are typically noticed within 4–8 weeks. Cardiovascular benefits operate over years of consistent use rather than weeks - this is a long-term investment compound. Some people notice no subjective change while still accruing the relevant cardiovascular antioxidant benefit.
Safety and watch for
Well tolerated. GI discomfort at high doses (above 300mg) is possible but not relevant at 100mg. CoQ10 taken in the evening can cause difficulty falling asleep in some individuals - morning timing is non-negotiable for your sleep goals. No prescription medications are present, so no warfarin interaction applies. No cycling required.
Form
Ubiquinol (reduced QH form) - not ubiquinone. Kaneka QH is the clinically studied brand; confirm "ubiquinol" on the label.
Daily dose
100mg Ubiquinol
When to take
Breakfast (with fat - morning only)
Introduce
Week 21
Evidence grade
A for cardiovascular outcomes in statin users and heart failure; B for general population and energy production
Goals addressed
Cardiovascular protection (family history) · Mitochondrial energy · Afternoon slump (secondary) · Longevity
Cycling
Continuous - no cycling required
What to look for
Label must state ubiquinol (not ubiquinone). Kaneka QH is the branded ingredient used in clinical trials and is widely available in UK supplements that license it. The form difference between ubiquinol and ubiquinone is clinically meaningful: ubiquinol is the reduced, bioavailable form that requires no conversion; ubiquinone requires reduction to ubiquinol in the body, a step that becomes progressively less efficient from the early thirties.
What to avoid
Ubiquinone-only CoQ10 products, which are more common and cheaper but less bioavailable for your age group. Products that do not specify the form (i.e. label states only "CoQ10" without specifying ubiquinol or ubiquinone - assume ubiquinone in this case).
Search: "Ubiquinol CoQ10 100mg Kaneka QH UK"
Phosphatidylserine
Optimise
Grade B
300mg
Why this compound
Phosphatidylserine (PS) is a phospholipid concentrated in neuronal cell membranes. It supports cognitive function through two distinct mechanisms: first, it maintains membrane fluidity and signal transduction efficiency in neurons, which is the structural basis for the FDA's qualified health claim for cognitive decline; second, and more relevant to your specific situation, it blunts the cortisol response to cognitive load. Under conditions of sustained mental work - your working day - cortisol rises incrementally with cognitive demand. High afternoon cortisol is a well-documented contributor to the afternoon cognitive slump because it shifts brain resource allocation away from prefrontal executive function.
The cortisol-blunting effect of PS at 300–400mg/day has been shown specifically in healthy adult populations under exercise and cognitive stress conditions (Monteleone 1990, 1992; Benton 2001), making it the compound most directly targeted at the 2–3pm slump beyond the B Complex. It works synergistically with Omega-3 through a brain membrane integrity mechanism: DHA in Omega-3 and PS work as complementary structural components of the same neuronal membranes.
Sunflower lecithin-derived PS is available and relevant only if you had a soy allergy, which is not present. Standard soy-derived PS is appropriate and is the form most commonly used in trials. Cortisol-blunting effects are typically measurable within 2–4 weeks of consistent use. Subjective cognitive improvement tends to be noticed in the 4–8 week window. Some people find the afternoon focus effect quite clear; others notice nothing subjectively while the underlying cortisol mechanism remains active. This is one of the harder compounds to self-assess because the mechanism is biochemical rather than felt directly as a stimulant effect.
The cortisol-blunting effect of PS at 300–400mg/day has been shown specifically in healthy adult populations under exercise and cognitive stress conditions (Monteleone 1990, 1992; Benton 2001), making it the compound most directly targeted at the 2–3pm slump beyond the B Complex. It works synergistically with Omega-3 through a brain membrane integrity mechanism: DHA in Omega-3 and PS work as complementary structural components of the same neuronal membranes.
Sunflower lecithin-derived PS is available and relevant only if you had a soy allergy, which is not present. Standard soy-derived PS is appropriate and is the form most commonly used in trials. Cortisol-blunting effects are typically measurable within 2–4 weeks of consistent use. Subjective cognitive improvement tends to be noticed in the 4–8 week window. Some people find the afternoon focus effect quite clear; others notice nothing subjectively while the underlying cortisol mechanism remains active. This is one of the harder compounds to self-assess because the mechanism is biochemical rather than felt directly as a stimulant effect.
Safety and watch for
Well tolerated at 300mg. GI discomfort is possible at higher doses (above 600mg) but not relevant here. Do not take in the evening - PS taken late in the day is associated with insomnia in some individuals, which would directly undermine your sleep goals. Midday or morning is the correct timing. No anticoagulant interaction applies given no prescription medications. The antiplatelet potency of PS at standard doses is classified as negligible - no meaningful platelet effect at 300mg/day.
Form
Soy-derived or sunflower-derived phosphatidylserine - both are effective. No soy allergy present, so standard soy-derived PS is appropriate.
Daily dose
300mg
When to take
Morning or midday (not evening)
Introduce
Week 23
Evidence grade
B - FDA qualified health claim for cognitive decline; multiple RCTs for cortisol and cognitive performance under load
Goals addressed
Mental clarity · Afternoon slump · Cortisol management under cognitive load · Memory (secondary)
Cycling
Continuous - no cycling required
Sourcing
Phosphatidylserine is widely available from reputable UK suppliers with no meaningful quality gap between brands at 300mg. Confirm the label states the dose as phosphatidylserine (not total lecithin - PS is a fraction of lecithin and the two are not equivalent). Some products list phosphatidylserine as a percentage of a larger lecithin complex; confirm you are hitting 300mg of actual PS.
Search term: "Phosphatidylserine 300mg soy-derived UK" or "PS 300mg sunflower lecithin UK"
Search term: "Phosphatidylserine 300mg soy-derived UK" or "PS 300mg sunflower lecithin UK"
Interactions Summary
Checked against your current medications, supplements, and full compound list
| Compounds / Medication | Verdict | Notes |
|---|---|---|
| Vitamin D3 + K2 - stack | Safe | K2 MK-7 is specifically paired with D3 to direct calcium to bone rather than soft tissue. No adverse interaction within the stack. Fat-soluble: take with a meal containing dietary fat. |
| Magnesium Glycinate + L-Theanine + Ashwagandha (evening combination) | Safe | All three have mild calming or GABA-modulating activity. Combined evening use is intentional and appropriate at the doses in this stack. Additive sedation is the goal, not a risk, at these doses. Avoid combining with alcohol on the same evening: additive sedating effect. |
| Magnesium Glycinate + Glycine + Apigenin (sleep stack) | Safe | Three complementary mechanisms: GABA-A agonism (Magnesium), NMDA modulation and core body temperature reduction (Glycine), and CD38 inhibition with mild anxiolytic activity (Apigenin). No adverse interactions. Combined use is appropriate for the mixed onset and maintenance sleep subtypes identified. |
| Ashwagandha + Rhodiola Rosea | Sequence carefully | Both are adaptogens and must not be introduced simultaneously. Ashwagandha is introduced first (calming, HPA-axis, sleep-supportive). Rhodiola is introduced a minimum of 12 weeks later. Rhodiola is stimulating and can worsen anxiety or cause sleep disruption if added too early or to a system that has not yet stabilised. See Introduction Schedule for correct sequencing. |
| Rhodiola Rosea - timing | Morning only | Rhodiola is mildly stimulating. Taking it after midday increases the risk of sleep disruption, which is a stated side effect priority for this client. Morning dose only, with breakfast. |
| Lion's Mane + Bacopa Monnieri (cognitive pair) | Safe | Well-documented synergy pair. Lion's Mane stimulates Nerve Growth Factor (NGF); Bacopa supports acetylcholine availability and memory consolidation. No adverse interactions. Bacopa requires 8–12 weeks of consistent use before full cognitive effects are apparent - set this expectation before assessing. |
| Phosphatidylserine + Omega-3 EPA/DHA | Safe - synergistic | Both support brain membrane integrity through complementary mechanisms. Combined use is appropriate and represents a well-established cognitive support pair. |
| Coenzyme Q10 - timing | Morning only | CoQ10 can cause insomnia or difficulty settling if taken in the evening. Morning dose with breakfast is mandatory given this client's sleep difficulties. Fat-soluble: requires dietary fat for absorption. |
| Vitamin B Complex - timing | Morning or midday only | B vitamins, particularly B6 and B12, can be mildly activating. Evening dosing may interfere with sleep onset. Take with breakfast or lunch. Do not take in the evening given the stated sleep onset difficulties. |
| Zinc Bisglycinate + Magnesium Glycinate | Safe - time apart | At high doses, zinc and magnesium compete for the same mineral transporters. At the doses in this stack (15–25mg zinc, 300–400mg elemental magnesium), this is not a meaningful concern. Zinc is timed with a meal; Magnesium before bed. Natural separation within the daily schedule. |
| Creatine Monohydrate (current supplement, Keep) + Omega-3 EPA/DHA | Safe - complementary | No adverse interaction. Omega-3 and Creatine address different performance mechanisms (anti-inflammatory and phosphocreatine resynthesis respectively). Both can be taken without timing constraints relative to each other. |
| Caffeine (dietary, 2 cups daily before noon) + Ashwagandha + L-Theanine | Safe - note | No pharmacological interaction. L-Theanine at 200mg before bed is not meaningfully affected by morning caffeine intake. Ashwagandha HPA-axis modulation is independent of caffeine. The afternoon energy slump driving additional caffeine use may improve as the Ashwagandha and B Complex stack establishes - track this over weeks 6–10 before adjusting caffeine habits further. |
| Alcohol (3–4 units/week, weekend pattern) + Magnesium Glycinate + L-Theanine + Ashwagandha + Glycine + Apigenin | Monitor | Alcohol intake is below the threshold for a formal sedation-interaction warning. Practical guidance: avoid combining the evening sleep stack (Magnesium Glycinate, L-Theanine, Glycine, Apigenin) with alcohol on the same evening. The additive CNS-depressant effect is manageable but will blunt the quality of sleep architecture benefits these compounds provide, counteracting the purpose of taking them. |
| Rhodiola Rosea + SSRI / serotonergic medications | Not applicable - note for future | Alex has no current prescription medications. If an SSRI or SNRI is ever prescribed in the future, Rhodiola must be discontinued before starting it. Flag this note in any future GP or pharmacy consultation. |
Sleep Stack Guidance
Personalised to your sleep pattern: onset difficulty and mid-night waking
Your sleep profile has two distinct components: difficulty falling asleep (onset) and waking once or twice during the night (maintenance). These respond to different mechanisms and this stack addresses both directly.
The onset issue points to elevated cortisol arousal at bedtime, likely amplified by the pattern of afternoon caffeine and sustained desk-based cognitive load. The maintenance waking points to HPA axis dysregulation: cortisol that bottoms out and then resurges during the night. Ashwagandha is the primary compound for the maintenance component; the remaining three work on sleep onset and depth.
Build this stack sequentially. Do not add all four compounds at once. Start with Magnesium Glycinate in Week 2 (Foundation). Add L-Theanine at Week 9 once Ashwagandha is established. Glycine follows at Week 11, and Apigenin at Week 13. This gives you clear attribution if any compound does not suit you.
| Compound | Dose | When | Mechanism |
|---|---|---|---|
| Magnesium Glycinate | 300–400mg elemental | 45–60 min before bed | GABA-A receptor potentiation and NMDA modulation. Reduces the cortisol arousal signal that keeps the nervous system elevated at bedtime. Addresses onset and contributes to depth. |
| Ashwagandha KSM-66 | 300mg KSM-66 | Evening, with dinner or 1 hr before bed | HPA axis regulation via cortisol modulation. Primary compound for mid-night waking. Reduces the cortisol rebound pattern associated with waking once or twice in the second half of the night. Effects on sleep maintenance typically become noticeable at 4–6 weeks of consistent use. |
| Glycine | 3g | 30 min before bed | Lowers core body temperature via peripheral vasodilation - the same mechanism that occurs naturally as sleep onset approaches. Also acts as an inhibitory neurotransmitter in the brainstem. Supports both onset and sleep architecture quality. |
| Apigenin | 50mg | 30 min before bed | Binds to GABA-A receptors at the benzodiazepine site with a mild anxiolytic and sedative effect. Also inhibits CD38, the enzyme that degrades NAD+. Paired with Glycine for sleep architecture support. Non-habit-forming at this dose. |
| L-Theanine | 200mg | 30–45 min before bed | Increases alpha-wave brain activity and raises GABA levels. Reduces the ruminative, anxious mental activity that delays sleep onset without causing morning grogginess. Complementary to Magnesium Glycinate rather than duplicative. |
A note on the afternoon caffeine pattern. The 2–3pm energy slump driving a second coffee is likely shortening your sleep window and delaying your circadian wind-down. As Ashwagandha and B Complex establish over weeks 6–10, many people find the afternoon slump moderates. If it persists at 12 weeks, consider whether the second coffee is serving you - an earlier cut-off (before 1pm) is worth trialling before adding any further compounds for energy.
Valerian Root: deferred. Valerian is relevant for sleep onset and was considered for this stack. It was not included at this stage because the onset dimension is already addressed by three compounds (Magnesium Glycinate, L-Theanine, Glycine) and the maintenance dimension by Ashwagandha. Adding Valerian now would make attribution impossible. It is flagged in the Reassessment Framework as a candidate if onset difficulty persists after 8 weeks of the current sleep stack.
Melatonin: not recommended for regular use. Melatonin is most useful for circadian disruption: jet lag, shift work, significant schedule changes. For your sleep profile, which involves an intact circadian rhythm with onset and maintenance problems rather than a timing mismatch, nightly melatonin is unlikely to be the right tool and may suppress endogenous production over time. The compounds above address the underlying mechanisms more directly.
Reassessment Framework
This report is a starting point, not a fixed prescription
Supplements work on timescales of weeks to months, not days. The compounds in your stack have different onset windows: Magnesium Glycinate and L-Theanine may produce noticeable effects within 1–2 weeks; Ashwagandha typically requires 4–6 weeks; Bacopa Monnieri needs 8–12 weeks before its cognitive effects are meaningful. Do not assess the full stack at 4 weeks. Assess it properly at 12 weeks.
12-Week Review: What to Test- Vitamin D (25-OHD): Retest at 12 weeks. Target range: 100–150 nmol/L. If below 75 nmol/L, dose may need to increase with GP guidance. If above 200 nmol/L, reduce dose.
- Ferritin: If the energy slump and afternoon fatigue persist despite the full stack being established, ferritin is the most important test to run. Request ferritin specifically (not just haemoglobin or full blood count) and ask for your number - not just "normal." Optimal functional range for energy and cognition is above 50 µg/L even if the laboratory reference range is lower.
- Lipid panel (total cholesterol, LDL, HDL, triglycerides): Recommended regardless of supplement status given first-degree relative CVD at age 62. Establishes a baseline and informs whether the cardiovascular elements of this stack (Omega-3, CoQ10) should be prioritised further or dosing adjusted.
- Fasting glucose or HbA1c: Useful metabolic baseline given family history. No current symptoms, but worth knowing your number at 34.
- Testosterone (total and free): Optional but useful baseline for a 34-year-old male with fatigue and an active training schedule. Ashwagandha may modestly raise testosterone in men with sub-optimal levels - a pre-stack baseline allows you to assess this.
- Sleep onset time: how long before you feel sleep is coming. Track this informally - note whether the 30–40 minute lying-awake window shortens over weeks 2–6.
- Night waking frequency: whether the once or twice per night pattern changes after Ashwagandha is established (weeks 6–10).
- Afternoon energy: whether the 2–3pm slump moderates as B Complex and Ashwagandha establish. Note whether you reach for the second coffee less often.
- Cognitive clarity and sustained focus: Bacopa requires patience. Do not assess this until at least week 10. Lion's Mane may produce earlier subjective changes (weeks 4–6) in some people.
- Any digestive symptoms: Bacopa with food is non-negotiable for GI tolerance. If any compound causes persistent GI upset, stop it, identify it, and note in the reassessment.
- Valerian Root (300–600mg): If sleep onset difficulty persists after 8 weeks of the current sleep stack, Valerian is the logical next addition. Combine with the existing Magnesium Glycinate and L-Theanine. Do not use continuously beyond 4–6 weeks without a break.
- Lemon Balm (300–600mg): Adjunct for sleep onset if Valerian alone is insufficient. Valerian and Lemon Balm have superior combined evidence compared to either alone.
- NAC (N-Acetyl Cysteine, 600mg twice daily): If longevity becomes a higher priority at any point, pairing NAC with the existing Glycine creates the GlyNAC combination, which has meaningful emerging evidence for mitochondrial function and oxidative stress. This can be added without removing anything already in the stack.
- NMN or NR (500mg/day): Longevity compounds appropriate from age 40+. Defer until then. No cancer history is a confirmed gate. Revisit in your 40+ reassessment.
- Berberine: If blood work at 12 weeks shows elevated fasting glucose, elevated LDL, or if weight management becomes a goal, Berberine is the highest-value addition to consider. It would require GP awareness given its blood-glucose-lowering effect.
- Magnesium L-Threonate: If cognitive demands increase significantly or family history of dementia becomes a concern, Magnesium L-Threonate is a meaningful upgrade for brain-specific magnesium delivery. Assess at 40+ alongside any emerging cognitive goals.
- Citicoline (250–500mg): A candidate to consider at reassessment if sustained focus and mental energy remain the primary frustration despite Lion's Mane and Bacopa being established. Must be taken in the morning only given its activating effect.
- Ashwagandha: Safe for continuous use up to 12 months based on current safety data. Do not stop abruptly after 8 or more weeks of use: taper over 1–2 weeks. Annual reassessment of whether to continue is appropriate.
- Rhodiola Rosea: 12 weeks on, 4 weeks off. This is not optional - adaptogen habituation is a documented phenomenon and cycling maintains responsiveness. Plan your first off-period into your 12-week review.
- Bacopa Monnieri: Continuous use for the first 12 weeks minimum. After that, reassess based on cognitive outcomes. Some people cycle; others continue indefinitely. GI tolerance with food is the primary limiting factor.
- Creatine (current): Continue at 5g/day indefinitely. No cycling required - there is no evidence that cycling Creatine confers any benefit.
Evidence References
Key studies informing this stack
- [1] A Holick MF et al. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96(7):1911–1930. Basis for Vitamin D3 dosing targets and repletion thresholds.
- [2] A Pilz S et al. Vitamin D and testosterone in healthy men: a clinical study. Horm Metab Res. 2011;43(3):223–225. Also: systematic review by Nimptsch K et al. Habitual dietary intake of vitamin D and calcium in relation to colorectal cancer - supports broad D3 immune and endocrine role at adequate serum levels.
- [3] A Abbasi B et al. The effect of magnesium supplementation on primary insomnia in elderly: a double-blind placebo-controlled clinical trial. J Res Med Sci. 2012;17(12):1161–1169. Supports Magnesium Glycinate for sleep quality and onset.
- [4] A Miller PE et al. Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials. Am J Hypertension. 2014;27(7):885–896. Basis for Omega-3 cardiovascular dosing and family-history CVD prioritisation.
- [5] A Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol. 2011;58(20):2047–2067. Supports EPA-dominant Omega-3 in first-degree relative CVD profiles.
- [6] A Prasad AS. Zinc in human health: effect of zinc on immune cells. Mol Med. 2008;14(5-6):353–357. Also: Zinc as cofactor in testosterone biosynthesis: Prasad AS et al. Nutrition. 1996;12(5):344–348. Supports Zinc Bisglycinate at 15–25mg.
- [7] A Kennedy DO. B vitamins and the brain: mechanisms, dose and efficacy - a review. Nutrients. 2016;8(2):68. Supports B Complex (active forms) for sustained cognitive energy and neurotransmitter cofactor roles.
- [8] A Chandrasekhar K et al. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012;34(3):255–262. Primary KSM-66 RCT basis for cortisol modulation and stress resilience.
- [9] B Langade D et al. Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety. Medicine (Baltimore). 2019;98(37):e17186. Supports Ashwagandha KSM-66 for sleep maintenance improvement at 600mg/day.
- [10] B Kimura K et al. L-Theanine reduces psychological and physiological stress responses. Biol Psychol. 2007;74(1):39–45. Supports L-Theanine 200mg for alpha-wave induction and sleep onset.
- [11] B Bannai M, Kawai N. New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep. J Pharmacol Sci. 2012;118(2):145–148. Core Glycine sleep RCT: 3g before bed reduces sleep latency and improves subjective sleep quality via core body temperature lowering mechanism.
- [12] C Mao JJ et al. Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder. Phytomedicine. 2016;23(14):1735–1742. Apigenin as primary active constituent of chamomile: GABA-A receptor binding and anxiolytic mechanism.
- [13] B Mori K et al. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother Res. 2009;23(3):367–372. Primary Lion's Mane RCT. NGF stimulation and cognitive improvement in a human population.
- [14] B Stough C et al. Examining the nootropic effects of a special extract of Bacopa monniera on human cognitive functioning: 90-day double-blind placebo-controlled randomized trial. Phytother Res. 2008;22(12):1629–1634. Establishes 8–12 week onset for Bacopa and working memory improvement in adults.
- [15] A Kongkeaw C et al. Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract. J Ethnopharmacol. 2014;151(1):528–535. Meta-analysis confirming Bacopa's cognitive effects, particularly on memory and speed of information processing.
- [16] B Darbinyan V et al. Rhodiola rosea in stress induced fatigue - a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine. 2000;7(5):365–371. Supports Rhodiola for cognitive fatigue and stress resilience in working adults.
- [17] B Spasov AA et al. A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period. Phytomedicine. 2000;7(2):85–89. Supports Rhodiola for stress-related cognitive fatigue in young adults.
- [18] A Sarter B. Coenzyme Q10 and cardiovascular disease: a review. J Cardiovasc Nurs. 2002;16(4):9–20. Also: Mortensen SA et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO. JACC Heart Fail. 2014;2(6):641–649. Basis for CoQ10 Ubiquinol in clients with family history CVD.
- [19] B Kato-Kataoka A et al. Soybean-derived phosphatidylserine improves memory function of the elderly Japanese subjects with memory complaints. J Clin Biochem Nutr. 2010;47(3):246–255. Supports Phosphatidylserine for memory and cognitive performance; combined with Omega-3 for brain membrane integrity.
- [20] B Witte AV et al. Long-chain omega-3 fatty acids improve brain function and structure in older adults. Cereb Cortex. 2014;24(11):3059–3068. Supports Omega-3 DHA for brain structure and cognitive function; combined with Phosphatidylserine in this stack for synergistic brain membrane support.
- [21] A Rawson ES, Volek JS. Effects of creatine supplementation and resistance training on muscle strength and weightlifting performance. J Strength Cond Res. 2003;17(4):822–831. Supports continued Creatine Monohydrate 5g/day for resistance training performance. No cycling required.
A
Strong evidence
Multiple RCTs or systematic reviews. Effect replicated across populations.
B
Good evidence
At least one well-designed RCT. Effect is consistent but limited replication.
C
Emerging evidence
Mechanistic data, observational studies, or small trials. Effect plausible but not yet confirmed at scale.
Limitations
What this report cannot do
This report is not a substitute for clinical consultation. It does not diagnose medical conditions, replace blood test interpretation by a qualified clinician, or constitute medical advice. All compound selections are based on peer-reviewed evidence, but individual response varies significantly. The fact that a compound has Grade A evidence in a population study does not guarantee you will respond to it in the same way, on the same timeline, or at the same dose.
No blood work was available at the time of this report. Vitamin D dosing in particular is calibrated from population-level defaults for an office-based male in the UK with limited sun exposure. A 25-OHD test before starting, and again at 12 weeks, is strongly recommended to confirm the dose is appropriate for your individual baseline. Similarly, the energy and fatigue picture cannot be fully interpreted without ferritin data. Both tests are available on request via your GP and many private providers.
The family history of cardiovascular disease in a first-degree relative, diagnosed at age 62, is a genuine risk modifier. The compounds in this stack that address cardiovascular health (Omega-3, CoQ10) are appropriate and evidence-based, but they are not a substitute for a lipid panel and blood pressure assessment with your GP. Supplements do not replace medical monitoring of cardiovascular risk factors.
This report reflects your profile at the time of completion. Goals change, circumstances change, and the evidence base evolves. A full reassessment at 6 months using an updated questionnaire will produce a more accurate picture than this one, particularly once blood work is available. The Reassessment Framework above sets out exactly what to test and when.
If you begin any prescription medication between now and your reassessment, review this report for relevant interactions before continuing your supplement stack. In particular, if an SSRI or SNRI is ever prescribed, Rhodiola Rosea must be discontinued before starting it.
One last note.
Your top priorities coming into this report were energy and mental clarity, better sleep, and stress resilience. These three goals are more connected than they might appear in isolation: the cortisol pattern driving your mid-afternoon slump is very likely the same pattern behind the 30–40 minutes of lying awake at night and the mid-night waking. The stack is built with that thread in mind. Supplements are one part of the picture, but the basics still matter: movement (which you are already doing, consistently), food timing (breakfast matters more than most people think for afternoon energy), and the caffeine cut-off are worth tracking alongside the compounds you are adding.
Track changes at 6 weeks and assess properly at 12. If something causes digestive discomfort or feels wrong, stop that compound and make a note. Getting in touch is always an option.
"Take care of your body. It's the only place you have to live."
Jim Rohn
You have been running on caffeine, willpower, and an interrupted night's sleep for long enough. The pattern is recognisable, and the fact that you have taken the time to address it thoughtfully rather than just adding another coffee is the most useful thing you could have done. The compounds in this stack may take weeks to show their full effect, and that is exactly as it should be: the goal is sustainable function, not a quick fix. Many people with a similar profile to yours find the sleep and afternoon energy picture meaningfully improved by weeks 8–10, once Ashwagandha is established and the Foundation compounds have had time to work. Give it the time it needs.
Wishing you well on your journey, Alex.
Track changes at 6 weeks and assess properly at 12. If something causes digestive discomfort or feels wrong, stop that compound and make a note. Getting in touch is always an option.
"Take care of your body. It's the only place you have to live."
Jim Rohn
You have been running on caffeine, willpower, and an interrupted night's sleep for long enough. The pattern is recognisable, and the fact that you have taken the time to address it thoughtfully rather than just adding another coffee is the most useful thing you could have done. The compounds in this stack may take weeks to show their full effect, and that is exactly as it should be: the goal is sustainable function, not a quick fix. Many people with a similar profile to yours find the sleep and afternoon energy picture meaningfully improved by weeks 8–10, once Ashwagandha is established and the Foundation compounds have had time to work. Give it the time it needs.
Wishing you well on your journey, Alex.
Legal Disclaimer
This report is provided for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment, and is not a substitute for professional medical advice from a qualified healthcare provider who is familiar with your individual medical history.
Distil is not a medical organisation. The recommendations in this report are based on publicly available peer-reviewed research and are intended as general information only. Individual results may vary and are not guaranteed.
Always consult your GP, pharmacist, or appropriate specialist before starting any new supplement, particularly if you are pregnant, breastfeeding, trying to conceive, have a diagnosed medical condition, are taking prescription medication, or have surgery planned. Some compounds may interact with medications or exacerbate certain health conditions.
The inclusion of a compound in this report does not constitute an endorsement of any specific product, brand, or manufacturer. Verify the legal status and safety of any supplement before purchase. Distil accepts no liability for any loss, injury, or damage arising from reliance on the information contained in this report. Use of this report is subject to Distil's Terms and Conditions at distil.health/terms.
Distil
Evidence, not assumptions.